Oral spore vaccine based on live attenuated nontoxinogenic Bacillus anthracis expressing recombinant mutant protective antigen.
about
Anthrax vaccination strategiesFrequent and seasonally variable sublethal anthrax infections are accompanied by short-lived immunity in an endemic systemEfficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthraxAnthrax prevention and treatment: utility of therapy combining antibiotic plus vaccine.Recombinant anthrax toxin receptor-Fc fusion proteins produced in plants protect rabbits against inhalational anthrax.Search for Bacillus anthracis potential vaccine candidates by a functional genomic-serologic screen.Microarray analysis of transposon insertion mutations in Bacillus anthracis: global identification of genes required for sporulation and germination.Identification of in vivo-expressed immunogenic proteins by serological proteome analysis of the Bacillus anthracis secretome.The role of nuclear technologies in the diagnosis and control of livestock diseases--a reviewThe Exosporium Layer of Bacterial Spores: a Connection to the Environment and the Infected HostNext-Generation Bacillus anthracis Live Attenuated Spore Vaccine Based on the htrA(-) (High Temperature Requirement A) Sterne Strain.Bacillus anthracis: interactions with the host and establishment of inhalational anthrax.Potential biological targets of Bacillus anthracis in anti-infective approaches against the threat of bioterrorism.Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.Proteomic studies of Bacillus anthracis.The solute-binding component of a putative Mn(II) ABC transporter (MntA) is a novel Bacillus anthracis virulence determinant.The International Bacillus anthracis, B. cereus, and B. thuringiensis Conference, "Bacillus-ACT05".Expression and display of a novel thermostable esterase from Clostridium thermocellum on the surface of Bacillus subtilis using the CotB anchor protein.
P2860
Q28392248-EC81BBC0-6925-47E9-8B53-8227E482F780Q28654914-64E231A6-1AEC-4187-8579-D3BAC81517B8Q33396429-EEC5A3E1-2EC7-4462-B031-75B32EE5FCA6Q33505445-0A3788B9-159E-417C-A10E-C1AB08489130Q34483688-780E3895-EFE2-48A3-9335-F71355F9C554Q34721071-EDC280B2-7337-407E-B4B4-DDE7C60C528DQ35759602-8CC490BC-8D7C-4298-8AFA-DB918C347664Q35913411-ADACB736-29F2-4C39-B8B9-41962ED295CEQ36208169-5706E39D-5F82-4782-8033-14EE78A3DAD2Q36294717-97C13316-B610-4D1E-8D93-21B0F3B70CF1Q36432828-CEC34E27-4844-4843-8033-4AE41612DBFAQ36895609-2FD56FD1-4F7B-4316-97C6-1C64293CA93AQ36901955-82677524-5D51-4583-ABD7-878E0908AC15Q37404847-09404B14-BE7C-4D06-98AC-1B309EAF0956Q37613667-34364925-083D-4CFA-9DFD-BF3894E7F4D1Q40384956-2E3C3103-056F-4241-8756-D65A4A616582Q42397574-64B250C2-4CD8-407C-9B0E-EA31351D3E39Q43025487-E6814A52-5539-4EE0-A29F-96BBBE29C8D3
P2860
Oral spore vaccine based on live attenuated nontoxinogenic Bacillus anthracis expressing recombinant mutant protective antigen.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Oral spore vaccine based on li ...... ant mutant protective antigen.
@ast
Oral spore vaccine based on li ...... ant mutant protective antigen.
@en
type
label
Oral spore vaccine based on li ...... ant mutant protective antigen.
@ast
Oral spore vaccine based on li ...... ant mutant protective antigen.
@en
prefLabel
Oral spore vaccine based on li ...... ant mutant protective antigen.
@ast
Oral spore vaccine based on li ...... ant mutant protective antigen.
@en
P2093
P2860
P1476
Oral spore vaccine based on li ...... ant mutant protective antigen.
@en
P2093
P2860
P304
P356
10.1128/IAI.73.7.4043-4053.2005
P4011
35f8d74222ced64c4f28c05b059dd03f891acea1
P407
P577
2005-07-01T00:00:00Z